Blog
RSS FeedPosted by Michael Wonder on 22 Aug 2022
National Medicines Policy review – registrations for targeted stakeholder consultation sessions and open public forum
22 August 2022 - The Department of Health and Aged Care is inviting stakeholders to provide feedback on the revised ...
Posted by Michael Wonder on 18 Aug 2022
Restart of National Medicines Policy Review is welcome, but assurances needed over further consultation and feedback processes
18 August 2022 - Medicines Australia welcomes the restart of the National Medicines Policy Review, which was put on hold ...
Posted by Michael Wonder on 17 Aug 2022
COVID vaccine rollout too slow, poorly planned, audit finds
17 August 2022 - An audit of Australia’s coronavirus vaccination rollout has criticised the slow speed at which early doses ...
Posted by Michael Wonder on 17 Aug 2022
Restart of the National Medicines Policy review – further consultation on a revised draft
17 August 2022 - The Department of Health and Aged Care is inviting stakeholders to provide feedback on a revised ...
Posted by Michael Wonder on 15 Aug 2022
One stop shop in Medicare shake-up
16 August 2022 - Doctors may be able to spend more time with patients, treat patients after-hours, and employ nurses, ...
Posted by Michael Wonder on 13 Jun 2022
Medicines Australia moves quickly to put HTA system reform high on new Government’s agenda
10 June 2022 - Medicines Australia has moved quickly to ensure that major reform of Australia’s health technology assessment system ...
Posted by Michael Wonder on 25 May 2022
Review of discount rate in the PBAC Guidelines
25 May 2022 - The Commonwealth has entered into a new Strategic Agreement in relation to reimbursement, health technology assessment ...
Posted by Michael Wonder on 19 May 2022
Medicines Australia puts spotlight on reform priority for the next Government
20 May 2022 - Medicines Australia has set the scene for major health reform by the next Government by alerting ...
Posted by Michael Wonder on 17 May 2022
Discount rate adjustment for the health of future generations
17 May 2022 - Medicines Australia has released a video detailing the need for Australia to adjust its discount rate ...
Posted by Michael Wonder on 09 May 2022
Next Health Minister must restart the National Medicines Policy Review
10 May 2022 - Medicines Australia has released a video outlining the importance of restarting the National Medicines Policy Review ...
Posted by Michael Wonder on 02 May 2022
What is the HTA review and why is it important for Australia’s health system?
3 May 2022 - Medicines Australia has released its fourth video in its Federal Election series, explaining the upcoming independent ...
Posted by Michael Wonder on 10 Apr 2022
Health Technology Assessment Review Reference Committee will drive reform to support Australian patients
10 April 2022 - The Health Technology Assessment Review Reference Committee announced (via the Department of Health website) is tasked ...
Posted by Michael Wonder on 09 Apr 2022
Life Saving Drugs Program – medicines reviews recommendations
7 April 2022 - This document outlines 51 recommendations from the Life Saving Drugs Expert Panel review. ...
Posted by Michael Wonder on 05 Apr 2022
Consultation now open - review of base case discount rate at 3A.1 of the PBAC Guidelines
5 April 2022 - The Commonwealth has entered into a new Strategic Agreement in relation to reimbursement, health technology assessment ...
Posted by Michael Wonder on 25 Mar 2022
DUSC utilisation analysis public release documents
25 March 2022 - The utilisation analysis public release documents from the October 2021 DUSC meeting are now available. ...